The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,741.50
Bid: 1,741.50
Ask: 1,742.00
Change: 1.50 (0.09%)
Spread: 0.50 (0.029%)
Open: 1,730.00
High: 1,745.00
Low: 1,729.00
Prev. Close: 1,740.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Macquarie Raises Banks, HSBC Lowers Grocers

Wed, 06th Jul 2016 08:32

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
BARCLAYS RAISES CENTRICA PRICE TARGET TO 240 (230) PENCE - 'EQUAL WEIGHT'
----------
HSBC RAISES SSE SCOTTISH & SOUTHERN PRICE TARGET TO 1660 (1600) PENCE - 'HOLD'
----------
BARCLAYS CUTS EASYJET PRICE TARGET TO 1150 (1630) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS IAG PRICE TARGET TO 420 (700) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES ARM HOLDINGS PRICE TARGET TO 1300 (1250) PENCE - 'OVERWEIGHT'
----------
Liberum Ups Shire Target To 5,500p From 4,700p, Keeps Buy
----------
SOCGEN CUTS MARKS & SPENCER PRICE TARGET TO 307 (424) PENCE - 'HOLD'
----------
HSBC CUTS SAINSBURY(J) PRICE TARGET TO 165 (175) PENCE - 'REDUCE'
----------
HSBC CUTS MORRISON SUPERMARKETS TO 'REDUCE' ('HOLD') - TARGET 135 (165) PENCE
----------
HSBC CUTS TESCO TO 'HOLD' ('BUY') - TARGET 195 (240) PENCE
----------
TRADERS: HSBC REMOVES TESCO FROM 'EUROPE SUPER TEN LIST'
----------
TRADERS: HSBC ADDS GLAXOSMITHKLINE TO 'EUROPE SUPER TEN LIST'
----------
UBS RAISES BURBERRY GROUP PRICE TARGET TO 1700 (1550) PENCE - 'BUY'
----------
BERENBERG RAISES RELX PRICE TARGET TO 1425 (1400) PENCE - 'BUY'
----------
BERENBERG RAISES INFORMA PRICE TARGET TO 750 (725) PENCE - 'HOLD'
----------
MACQUARIE RAISES LLOYDS TO 'OUTPERFORM' (NEUTRAL) - PRICE TARGET 65 (70) PENCE
----------
MACQUARIE CUTS BARCLAYS PRICE TARGET TO 175 (230) PENCE - 'OUTPERFORM'
----------
MACQUARIE RAISES RBS TO 'OUTPERFORM' ('NEUTRAL') - TARGET 200 (220) PENCE
----------
FTSE 250
----------
TRADERS: NUMIS RAISES FIDESSA GROUP TO 'BUY' ('ADD')
----------
HSBC INITIATES TULLETT PREBON WITH 'BUY' - TARGET 380 PENCE
----------
Numis Cuts PageGroup To Add From Buy, Target To 320p From 530p
----------
Numis Cuts Hays To Add From Buy, Target To 110p From 155p
----------
BARCLAYS CUTS WIZZ AIR PRICE TARGET TO 1840 (2200) PENCE - 'OVERWEIGHT'
----------
TRADERS: JPMORGAN RESUMES VECTURA GROUP WITH 'OVERWEIGHT' - TARGET 230 PENCE
----------
TRADERS: DEUTSCHE BANK INITIATES TALK TALK TELECOM WITH 'BUY' - TARGET 300 P
----------
TRADERS: DEUTSCHE BANK RAISES VEDANTA RESOURCES TO 'BUY' ('HOLD')
----------
HSBC CUTS PAGEGROUP TO 'HOLD' ('BUY') - TARGET 320 (510) PENCE
----------
HSBC CUTS HAYS TO 'HOLD' ('BUY') - TARGET 110 (155) PENCE
----------
HSBC RAISES FIRSTGROUP PRICE TARGET TO 105 (100) PENCE - 'HOLD'
----------
HSBC RAISES STAGECOACH GROUP PLC TO 'HOLD' ('REDUCE') - TARGET 235 PENCE
----------
HSBC CUTS ELECTROCOMPONENTS TO 'HOLD' ('BUY') - TARGET 240 (290) PENCE
----------
TRADERS: HSBC CUTS GREAT PORTLAND TO 'HOLD' ('BUY')
----------
TRADERS: HSBC RAISES CAPITAL & COUNTIES TO 'HOLD' ('REDUCE')
----------
BERENBERG RAISES UBM PLC PRICE TARGET TO 640 (610) PENCE - 'HOLD'
----------
TRADERS: GOLDMAN CUTS WEIR GROUP TO 'BUY' ('CONVICTION BUY LIST')
----------
MAIN MARKET AND AIM
----------
SHORE CAPITAL RESUMES SAVANNAH PETROLEUM WITH 'BUY'
----------
Numis Cuts SThree Target To 280p From 330p, Keeps Hold
----------
HSBC CUTS STHREE TO 'HOLD' ('BUY') - TARGET 270 (405) PENCE
----------
Numis Cuts Robert Walters To Hold From Buy, Target To 275p From 445p
----------
BARCLAYS CUTS GULF MARINE PRICE TARGET TO 57 (95) PENCE - 'EQUAL WEIGHT'
----------
Cantor Ups Good Energy Group Target To 250p From 230p, Keeps Buy
----------
LIBERUM RAISES MJ GLEESON PRICE TARGET TO 526 (520) PENCE - 'BUY'
----------
Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.